AMZ30

CAS No. 1313613-09-0

AMZ30( —— )

Catalog No. M19957 CAS No. 1313613-09-0

AMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 112 In Stock
5MG 67 In Stock
10MG 103 In Stock
25MG 174 In Stock
50MG 258 In Stock
100MG 381 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AMZ30
  • Note
    Research use only, not for human use.
  • Brief Description
    AMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
  • Description
    AMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PME-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1313613-09-0
  • Formula Weight
    461.44
  • Molecular Formula
    C19H12FN3O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 4 mg/mL
  • SMILES
    [O-][N+](=O)c1cccc(c1)S(=O)(=O)n1cccc1\C=C(/C#N)S(=O)(=O)c1ccc(F)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bachovchin DA et al. Discovery and optimization of sulfonyl acrylonitriles as selective covalent inhibitors of protein phosphatase methylesterase-1. J Med Chem. 2011 Jul 28;54(14):5229-36.
molnova catalog
related products
  • 34-Dihydroxyflavone

    34-Dihydroxyflavone Acts as an Antioxidant and Antiapoptotic Agent .

  • GSK-J2

    GSK-J2 is an inactive enantiomer of GSK-J1 that is lipophilic and serves as an inactive control for GSK-J21.

  • Gemcitabine elaidate...

    Gemcitabine elaidate (CP-4126) hydrochloride is a lipophilic pro-drug of Gemcitabine, converted to Gemcitabine by esterases for phosphorylation.